Dozens of Americans have filed personal injury lawsuits against the makers of popular GLP-1 drugs — like Ozempic, Wegovy and Mounjaro — claiming they were not properly warned of the risk of a rare type of sudden vision loss when taking the medications. ↧ What GLP-1 users should know about the potential risk of a rare typ... Dozens of Americans have filed personal injury lawsuits against GLP-1 makers, claiming they were not properly warned of the risk of a rare type of sudden vision loss.
published
Dozens of Americans have filed personal injury lawsuits against the makers of popular GLP-1 drugs — like Ozempic, Wegovy and Mounjaro — claiming they were not properly warned of the risk of a rare type of sudden vision loss when taking the medications.
Open the original public source →
Latest documented BWB result
$APP market result
Exit $APP Sold Puts for a nice profit and then sold more Puts - this time the $325's for $3.97
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.